New and Generic Drug Approvals (Aug 11):

*AZOR (amlodipine besylate and olmesartan medoxomil) Tablets, Daiichi Sankyo, Inc., Labeling Revision *Cefepime Injection, Baxter Healthcare Corp., Approval *CIALIS (tadalafil) Tablets, Eli Lilly and Co., Labeling Revision *Corzide (bendroflumethiazide and nadolol) Tablets, King Pharmaceuticals, Labeling Revision *FEMARA (letrozole) Tablets, Novartis Pharmaceuticals Corp., Labeling Revision *KERLONE (betaxolol hydrochloride) Tablets, Sanofi-Aventis US, LLC, Labeling Revision *Ramipril Capsules, Cipla Ltd, Approval *TALACEN (acetaminophen and pentazocine hydrochloride) Tablets, Sanofi-Aventis US, LLC, Labeling Revision 

Souce: FDA


Zynchros Pharmacy Services